$IDXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDEXX LABORATORIES INC /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IDEXX LABORATORIES INC /DE. Get notifications about new insider transactions in IDEXX LABORATORIES INC /DE for free.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 67.85 | 10,000 | 678,500 | 2,627 | |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 565.56 | 200 | 113,111 | 19,915 | 20.1 K to 19.9 K (-0.99 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 564.73 | 513 | 289,704 | 20,115 | 20.6 K to 20.1 K (-2.49 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 564.04 | 1,713 | 966,198 | 20,628 | 22.3 K to 20.6 K (-7.67 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 562.65 | 2,462 | 1,385,253 | 22,341 | 24.8 K to 22.3 K (-9.93 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 561.77 | 1,429 | 802,771 | 24,803 | 26.2 K to 24.8 K (-5.45 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 560.79 | 1,274 | 714,451 | 26,232 | 27.5 K to 26.2 K (-4.63 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 559.77 | 1,370 | 766,879 | 27,506 | 28.9 K to 27.5 K (-4.74 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Sell | S | 558.89 | 1,039 | 580,690 | 28,876 | 29.9 K to 28.9 K (-3.47 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 67.85 | 10,000 | 678,500 | 29,915 | 19.9 K to 29.9 K (+50.21 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 79.54 | 9,460 | 752,448 | 115,540 | |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 564.60 | 1,315 | 742,455 | 644,701 | 646 K to 644.7 K (-0.20 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 563.82 | 1,400 | 789,342 | 646,016 | 647.4 K to 646 K (-0.22 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 562.48 | 2,599 | 1,461,878 | 647,416 | 650 K to 647.4 K (-0.40 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 561.57 | 1,664 | 934,457 | 650,015 | 651.7 K to 650 K (-0.26 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 560.38 | 2,482 | 1,390,856 | 651,679 | 654.2 K to 651.7 K (-0.38 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 79.54 | 9,460 | 752,448 | 654,161 | 644.7 K to 654.2 K (+1.47 %) |
| Jun 01 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Gift | G | 0.00 | 9,000 | 0 | 644,701 | 653.7 K to 644.7 K (-1.38 %) |
| May 24 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Sell | S | 545.00 | 1,000 | 545,000 | 7,766 | 8.8 K to 7.8 K (-11.41 %) |
| May 24 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Sell | S | 540.00 | 1,000 | 540,000 | 8,766 | 9.8 K to 8.8 K (-10.24 %) |
| May 24 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Sell | S | 535.00 | 1,000 | 535,000 | 9,766 | 10.8 K to 9.8 K (-9.29 %) |
| May 24 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 79.54 | 5,000 | 397,700 | 135,000 | |
| May 24 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 538.18 | 415 | 223,346 | 653,701 | 654.1 K to 653.7 K (-0.06 %) |
| May 24 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 537.62 | 2,058 | 1,106,419 | 654,116 | 656.2 K to 654.1 K (-0.31 %) |
| May 24 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 536.43 | 2,527 | 1,355,559 | 656,174 | 658.7 K to 656.2 K (-0.38 %) |
| May 24 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 79.54 | 5,000 | 397,700 | 658,701 | 653.7 K to 658.7 K (+0.76 %) |
| May 20 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Gift | G | 0.00 | 500 | 0 | 55,209 | 55.7 K to 55.2 K (-0.90 %) |
| May 20 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 79.54 | 7,632 | 607,049 | 140,000 | |
| May 20 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 528.02 | 7,632 | 4,029,809 | 653,701 | 661.3 K to 653.7 K (-1.15 %) |
| May 20 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 79.54 | 7,632 | 607,049 | 661,333 | 653.7 K to 661.3 K (+1.17 %) |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Option Exercise | A | 512.31 | 723 | 370,400 | 723 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Option Exercise | A | 0.00 | 224 | 0 | 224 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Option Exercise | A | 512.31 | 723 | 370,400 | 723 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Option Exercise | A | 0.00 | 224 | 0 | 224 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | SAMAD SAM | Director | Option Exercise | A | 512.31 | 723 | 370,400 | 723 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | SAMAD SAM | Director | Option Exercise | A | 0.00 | 224 | 0 | 887 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Option Exercise | A | 512.31 | 252 | 129,102 | 975 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Option Exercise | A | 512.31 | 723 | 370,400 | 723 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Option Exercise | A | 0.00 | 78 | 0 | 302 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Option Exercise | A | 0.00 | 224 | 0 | 224 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 512.31 | 723 | 370,400 | 723 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | A | 0.00 | 224 | 0 | 3,387 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Option Exercise | A | 512.31 | 723 | 370,400 | 723 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Option Exercise | A | 0.00 | 224 | 0 | 224 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | COLLINS Asha | Director | Option Exercise | A | 512.31 | 723 | 370,400 | 723 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | COLLINS Asha | Director | Option Exercise | A | 0.00 | 224 | 0 | 333 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Option Exercise | A | 512.31 | 723 | 370,400 | 723 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Option Exercise | A | 0.00 | 224 | 0 | 2,552 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | A | 512.31 | 723 | 370,400 | 723 | |
| May 14 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | A | 0.00 | 224 | 0 | 224 | |
| May 12 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 542.46 | 2 | 1,085 | 653,701 | 653.7 K to 653.7 K (0.00 %) |
| May 12 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 541.01 | 510 | 275,915 | 653,703 | 654.2 K to 653.7 K (-0.08 %) |
| May 04 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Grant | A | 548.99 | 11 | 6,039 | 2,886 | 2.9 K to 2.9 K (+0.38 %) |
| May 04 2021 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 548.99 | 36 | 19,764 | 1,029 | 993 to 1 K (+3.63 %) |
| May 04 2021 | IDXX | IDEXX LABORATORIES ... | COLLINS Asha | Director | Grant | A | 548.99 | 36 | 19,764 | 78 | 42 to 78 (+85.71 %) |
| Mar 01 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | M | 67.85 | 3,227 | 218,952 | 0 | |
| Mar 01 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Buy | M | 67.85 | 3,227 | 218,952 | 16,950 | 13.7 K to 17 K (+23.52 %) |
| Mar 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 67.85 | 1,476 | 100,147 | 0 | |
| Mar 01 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 67.85 | 1,476 | 100,147 | 19,903 | 18.4 K to 19.9 K (+8.01 %) |
| Feb 25 2021 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Option Exercise | M | 160.28 | 3,046 | 488,213 | 0 | |
| Feb 25 2021 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Sell | S | 513.41 | 3,046 | 1,563,840 | 14,696 | 17.7 K to 14.7 K (-17.17 %) |
| Feb 25 2021 | IDXX | IDEXX LABORATORIES ... | HENDERSON REBECCA M | Director | Buy | M | 160.28 | 3,046 | 488,213 | 17,742 | 14.7 K to 17.7 K (+20.73 %) |
| Feb 25 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | M | 67.85 | 1,476 | 100,147 | 0 | |
| Feb 25 2021 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Buy | M | 67.85 | 1,476 | 100,147 | 654,213 | 652.7 K to 654.2 K (+0.23 %) |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Option Exercise | M | 206.94 | 483 | 99,952 | 1,449 | |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Buy | M | 206.94 | 483 | 99,952 | 1,878 | 1.4 K to 1.9 K (+34.62 %) |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 67.85 | 1,475 | 100,079 | 0 | |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 67.85 | 1,475 | 100,079 | 55,697 | 54.2 K to 55.7 K (+2.72 %) |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 85.00 | 1,000 | 85,000 | 4,902 | |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Option Exercise | M | 79.54 | 898 | 71,427 | 0 | |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 538.57 | 1,888 | 1,016,815 | 2,875 | 4.8 K to 2.9 K (-39.64 %) |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Sell | S | 539.19 | 10 | 5,392 | 4,763 | 4.8 K to 4.8 K (-0.21 %) |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 85.00 | 1,000 | 85,000 | 4,773 | 3.8 K to 4.8 K (+26.50 %) |
| Feb 24 2021 | IDXX | IDEXX LABORATORIES ... | JUNIUS DANIEL M | Director | Buy | M | 79.54 | 898 | 71,427 | 3,773 | 2.9 K to 3.8 K (+31.23 %) |
| Feb 19 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 67.85 | 1,474 | 100,011 | 0 | |
| Feb 19 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 67.85 | 1,474 | 100,011 | 26,188 | 24.7 K to 26.2 K (+5.96 %) |
| Feb 18 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Option Exercise | M | 160.28 | 1,125 | 180,315 | 1,921 | |
| Feb 18 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Option Exercise | M | 85.00 | 5,902 | 501,670 | 0 | |
| Feb 18 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Sell | S | 537.19 | 586 | 314,795 | 0 | 586 to 0 (-100.00 %) |
| Feb 18 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Sell | S | 536.89 | 6,745 | 3,621,293 | 586 | 7.3 K to 586 (-92.01 %) |
| Feb 18 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Buy | M | 160.28 | 1,125 | 180,315 | 7,331 | 6.2 K to 7.3 K (+18.13 %) |
| Feb 18 2021 | IDXX | IDEXX LABORATORIES ... | Claflin Bruce L. | Director | Buy | M | 85.00 | 5,902 | 501,670 | 6,206 | 304 to 6.2 K (+1,941.45 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 217 | 0 | 2,649 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 453 | 0 | 2,866 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Option Exercise | A | 0.00 | 551 | 0 | 3,349 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Option Exercise | A | 544.08 | 5,119 | 2,785,146 | 5,119 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Payment of Exercise | F | 544.08 | 208 | 113,169 | 1,395 | 1.6 K to 1.4 K (-12.98 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Buy | M | 0.00 | 217 | 0 | 1,603 | 1.4 K to 1.6 K (+15.66 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | SVP, Gen. Counsel & ... | Buy | M | 0.00 | 483 | 0 | 1,386 | 903 to 1.4 K (+53.49 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | M | 0.00 | 184 | 0 | 1,965 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | M | 0.00 | 157 | 0 | 2,149 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | M | 0.00 | 168 | 0 | 2,306 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | M | 0.00 | 212 | 0 | 2,474 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | M | 0.00 | 405 | 0 | 2,686 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | A | 0.00 | 459 | 0 | 3,091 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Option Exercise | A | 544.08 | 4,236 | 2,304,723 | 4,236 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Payment of Exercise | F | 544.08 | 338 | 183,899 | 13,723 | 14.1 K to 13.7 K (-2.40 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Buy | M | 0.00 | 184 | 0 | 14,061 | 13.9 K to 14.1 K (+1.33 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Buy | M | 0.00 | 157 | 0 | 13,877 | 13.7 K to 13.9 K (+1.14 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Buy | M | 0.00 | 168 | 0 | 13,720 | 13.6 K to 13.7 K (+1.24 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Buy | M | 0.00 | 212 | 0 | 13,552 | 13.3 K to 13.6 K (+1.59 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | Senior Vice Preside ... | Buy | M | 0.00 | 405 | 0 | 13,340 | 12.9 K to 13.3 K (+3.13 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | M | 0.00 | 163 | 0 | 2,005 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | M | 0.00 | 181 | 0 | 2,168 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | M | 0.00 | 210 | 0 | 2,349 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | M | 0.00 | 212 | 0 | 2,559 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | M | 0.00 | 221 | 0 | 2,771 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | A | 0.00 | 345 | 0 | 2,992 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Option Exercise | A | 544.08 | 3,131 | 1,703,514 | 3,131 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Payment of Exercise | F | 544.08 | 388 | 211,103 | 10,754 | 11.1 K to 10.8 K (-3.48 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Buy | M | 0.00 | 163 | 0 | 11,142 | 11 K to 11.1 K (+1.48 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Buy | M | 0.00 | 181 | 0 | 10,979 | 10.8 K to 11 K (+1.68 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Buy | M | 0.00 | 210 | 0 | 10,798 | 10.6 K to 10.8 K (+1.98 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Buy | M | 0.00 | 212 | 0 | 10,588 | 10.4 K to 10.6 K (+2.04 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Senior Vice Preside ... | Buy | M | 0.00 | 221 | 0 | 10,376 | 10.2 K to 10.4 K (+2.18 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 217 | 0 | 2,074 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 127 | 0 | 2,291 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 126 | 0 | 2,418 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 150 | 0 | 2,544 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 243 | 0 | 2,694 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 0.00 | 643 | 0 | 2,937 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 544.08 | 6,003 | 3,266,112 | 6,003 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Payment of Exercise | F | 544.08 | 257 | 139,829 | 18,427 | 18.7 K to 18.4 K (-1.38 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 217 | 0 | 18,684 | 18.5 K to 18.7 K (+1.18 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 127 | 0 | 18,467 | 18.3 K to 18.5 K (+0.69 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 126 | 0 | 18,340 | 18.2 K to 18.3 K (+0.69 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 126 | 0 | 18,340 | 18.2 K to 18.3 K (+0.69 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 150 | 0 | 18,214 | 18.1 K to 18.2 K (+0.83 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 243 | 0 | 18,064 | 17.8 K to 18.1 K (+1.36 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 433 | 0 | 5,850 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 435 | 0 | 6,283 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 505 | 0 | 6,718 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 459 | 0 | 7,223 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 810 | 0 | 7,682 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 0.00 | 1,011 | 0 | 8,492 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 544.08 | 183 | 99,567 | 183 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 544.08 | 9,538 | 5,189,435 | 9,538 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Sell | S | 539.58 | 1,307 | 705,231 | 24,714 | 26 K to 24.7 K (-5.02 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 544.08 | 1,335 | 726,347 | 26,021 | 27.4 K to 26 K (-4.88 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 433 | 0 | 27,356 | 26.9 K to 27.4 K (+1.61 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 435 | 0 | 26,923 | 26.5 K to 26.9 K (+1.64 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 505 | 0 | 26,488 | 26 K to 26.5 K (+1.94 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 459 | 0 | 25,983 | 25.5 K to 26 K (+1.80 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 810 | 0 | 25,524 | 24.7 K to 25.5 K (+3.28 %) |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 974 | 0 | 9,990 | |
| Feb 17 2021 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 435 | 0 | 10,964 |